The direct trial (daily-dose consensus interferon and ribavirin: efficacy of combined therapy): Treatment of non-responders to previous pegylated interferon plus ribavirin: Sustained virologic response data

被引：0
|
作者：
Bacon, Bruce
Regev, Arie
Ghalib, Reem H.
Morelli, Giuseppe
Rothstein, Kenneth D.
Shiffman, Mitchell L.
Hossanein, Tarek
Hammond, Janet
机构：
[1] St Louis Univ, Sch Med, Liver Ctr, St Louis, MO 63103 USA
[2] Univ Miami, Coral Gables, FL 33124 USA
[3] Methodist Hosp, Liver Inst, Dallas, TX USA
[4] Univ Florida, Gainesville, FL 32611 USA
[5] Albert Einstein Ctr Liver Dis, Philadelphia, PA USA
[6] Virginia Commonwealth Univ, Richmond, VA 23284 USA
[7] Univ Calif San Diego, La Jolla, CA 92093 USA
[8] Valeant Pharmaceut N Amer, Aliso Viejo, CA USA
来源：
HEPATOLOGY | 2007年 / 46卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
168
引用
收藏
页码：311A / 312A
页数：2
相关论文
共 50 条
  • [21] Influence of genotype, viral load and fibrosis on the sustained virologic response rate to pegylated interferon alpha-2a plus ribavirin, with or without amantadine, in chronic hepatitis C patients non-responders to alpha interferferon plus ribavirin
    Cheinquer, H.
    Pessoa, M.
    Sette, H., Jr.
    Parise, E.
    Parana, R.
    Tatsch, F.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S147 - S147
  • [22] Impaired sensitivity in non-responders to pegylated interferon plus ribavirin therapy assessed by 2′-5′-oligoadenylate synthetase activity
    Shindo, Michiko
    Hamada, Kazushige
    Morikawa, Teruhisa
    Harano, Yuichi
    Nakajima, Tomoaki
    Okuno, Tadao
    HEPATOLOGY, 2007, 46 (04) : 388A - 388A
  • [23] COMPARISON OF ROLLOVER VS WASHOUT DAILY INTERFERON ALFACON-1 AND RIBAVIRIN IN THE RETREATMENT OF NON-RESPONDERS TO PEGYLATED INTERFERON AND RIBAVIRIN FOR HEPATITIS C VIRUS INFECTION
    Fahmy, Marianne
    Gabbert, Charles
    Richards, Lisa
    Andrews, Barbara G.
    Kuo, Alexander
    HEPATOLOGY, 2010, 52 (04) : 814A - 815A
  • [24] Interferon plus ribavirin re-treatment in hemophilic patients relapsers or non-responders to interferon alone.
    Rumi, M
    Santagostino, E
    Soffredini, R
    Rivi, M
    Gringeri, A
    Colombo, M
    Mannucci, PM
    HEPATOLOGY, 2000, 32 (04) : 557A - 557A
  • [25] Peginterferon alpha-2b plus ribavirin with or without amantidine for the treatment of non-responders to standard interferon and ribavirin
    Hasan, F
    Al-Khaldi, J
    Asker, H
    Al-Ajmi, M
    Owayed, S
    Varghese, R
    Siddique, L
    Al-Nakib, B
    ANTIVIRAL THERAPY, 2004, 9 (04) : 499 - 503
  • [26] High ribavirin dose and extended treatment can raise sustained virologic response in chronic hepatitis C genotype 1 patients treated with simeprevir, pegylated interferon plus ribavirin
    Tahata, Yuki
    Hiramatsu, Naoki
    Oze, Tsugiko
    Urabe, Ayako
    Morishita, Naoki
    Yamada, Ryoko
    Yakushijin, Takayuki
    Saji, Yukiko
    Doi, Yoshinori
    Hagiwara, Hideki
    Kaneko, Akira
    Fukui, Hiroyuki
    Inada, Masami
    Katayama, Kazuhiro
    Inoue, Atsuo
    Yoshida, Yuichi
    Tatsumi, Tomohide
    Hayashi, Norio
    Takehara, Tetsuo
    HEPATOLOGY, 2015, 62 : 804A - 804A
  • [27] The efficacy of extended treatment with pegylated interferon plus ribavirin in patients with HCV genotype 1 and slow virologic response in Japan
    Oze, Tsugiko
    Hiramatsu, Naoki
    Yakushijin, Takayuki
    Mochizuki, Kiyoshi
    Imanaka, Kazuho
    Yamada, Akira
    Oshita, Masahide
    Kaneko, Akira
    Hagiwara, Hideki
    Mita, Eiji
    Ito, Toshifumi
    Nagase, Toshihiko
    Inui, Yoshiaki
    Hijioka, Taizo
    Tamura, Shinji
    Yoshihara, Harumasa
    Hayashi, Eijiro
    Imai, Yasuharu
    Kato, Michio
    Hosui, Atsushi
    Miyagi, Takuya
    Yoshida, Yuichi
    Ishida, Hisashi
    Tatsumi, Tomohide
    Kiso, Shinichi
    Kanto, Tatsuya
    Kasahara, Akinori
    Takehara, Tetsuo
    Hayashi, Norio
    JOURNAL OF GASTROENTEROLOGY, 2011, 46 (07) : 944 - 952
  • [28] Prolonged interferon treatment after combination interferon and ribavirin therapy in patients with chronic hepatitis C: A clinical trial of interferon relapsers and non-responders
    Kao, JH
    Lai, MY
    Chen, PJ
    Cheng, YM
    Chen, DS
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2001, 100 (10) : 662 - 667
  • [29] The efficacy of extended treatment with pegylated interferon plus ribavirin in patients with HCV genotype 1 and slow virologic response in Japan
    Tsugiko Oze
    Naoki Hiramatsu
    Takayuki Yakushijin
    Kiyoshi Mochizuki
    Kazuho Imanaka
    Akira Yamada
    Masahide Oshita
    Akira Kaneko
    Hideki Hagiwara
    Eiji Mita
    Toshifumi Ito
    Toshihiko Nagase
    Yoshiaki Inui
    Taizo Hijioka
    Shinji Tamura
    Harumasa Yoshihara
    Eijiro Hayashi
    Yasuharu Imai
    Michio Kato
    Atsushi Hosui
    Takuya Miyagi
    Yuichi Yoshida
    Hisashi Ishida
    Tomohide Tatsumi
    Shinichi Kiso
    Tatsuya Kanto
    Akinori Kasahara
    Tetsuo Takehara
    Norio Hayashi
    Journal of Gastroenterology, 2011, 46 : 944 - 952
  • [30] Pegylated-interferon plus ribavirin therapy in the treatment of CHC: individualization of treatment duration according to on-treatment virologic response
    Zeuzem, Stefan
    Poordad, Fred
    CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (07) : 1733 - 1743
12345